A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors

Clinical trial NCT03960060 · TERMINATED

Trial details

NCT number: NCT03960060
Sponsor: Shanghai PerHum Therapeutics Co., Ltd.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Soft Tissue Sarcoma Gastric Cancer Pancreatic Cancer Bladder Cancer

Start date: 2019-05-16
Primary completion: 2022-06-30
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.